| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.58T | 2.55T | 2.43T | 2.67T | 2.16T | 1.75T |
| Gross Profit | 143.33B | 140.61B | 119.84B | 128.54B | 119.01B | 79.92B |
| EBITDA | 73.14B | 71.58B | 59.16B | 71.67B | 68.88B | 35.18B |
| Net Income | 46.25B | 45.48B | 38.42B | 51.51B | 43.62B | 19.62B |
Balance Sheet | ||||||
| Total Assets | 1.14T | 1.17T | 1.17T | 1.16T | 1.72T | 824.59B |
| Cash, Cash Equivalents and Short-Term Investments | 74.42B | 65.31B | 76.53B | 84.19B | 165.45B | 50.91B |
| Total Debt | 377.32B | 382.33B | 365.45B | 380.98B | 722.94B | 301.65B |
| Total Liabilities | 754.26B | 776.33B | 810.22B | 848.94B | 1.47T | 632.73B |
| Stockholders Equity | 381.43B | 383.06B | 351.21B | 303.13B | 237.12B | 189.22B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.64B | 8.56B | 271.37B | -287.04B | 12.67B |
| Operating Cash Flow | 0.00 | 10.13B | 18.19B | 284.23B | -280.75B | 19.00B |
| Investing Cash Flow | 0.00 | -21.84B | 1.01B | -6.54B | -14.99B | -4.19B |
| Financing Cash Flow | 0.00 | 293.00M | -26.32B | -351.83B | 406.82B | -34.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥344.98B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
74 Outperform | ¥10.25T | 14.11 | 13.39% | 2.29% | 9.62% | 25.71% | |
71 Outperform | ¥16.32T | 16.87 | 15.23% | 2.11% | 0.93% | 15.80% | |
70 Outperform | ¥6.86T | 13.91 | 13.49% | 2.10% | 5.32% | 9.73% | |
67 Neutral | ¥17.89T | 17.68 | 11.47% | 2.28% | -1.33% | -7.40% | |
65 Neutral | ¥1.26T | 7.20 | 11.17% | 3.24% | 2.12% | 18.93% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |